Related Experiment Video
Updated: Mar 9, 2026

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy
Published on: January 25, 2019
RETRACTED: Recent advances in cardiac regeneration: Stem cell, biomaterial and growth factors
Mostafa Cheraghi1, Mehrdad Namdari1, Babak Negahdari2
1Department of Cardiology, Lorestan University of Medical Sciences, Khoramabad, Iran.
Insights
This review explores advances in cardiac regeneration after myocardial infarction, focusing on stem cells, biomaterials, and growth factors to improve treatment efficacy and patient outcomes.
Area of Science:
- Cardiovascular Research
- Regenerative Medicine
- Biomaterials Science
Background:
- Myocardial infarction causes millions of global deaths annually, with current treatments offering palliative rather than curative solutions.
- Limited protein/cell therapy half-life and low transplanted cell survival hinder effective cardiac regeneration post-myocardial infarction.
Purpose of the Study:
- To review recent advancements in cardiac regeneration strategies.
- To focus on the synergistic roles of stem cells, biomaterials, and growth factors in treating myocardial infarction.
Main Methods:
- Literature review of recent studies on cardiac regeneration.
- Analysis of stem cell therapies, biomaterial delivery systems, and growth factor applications.
- Discussion of challenges and future directions in the field.
Main Results:
- Stem cells show promise in regenerating cardiac tissue after myocardial infarction.
- Biomaterial delivery systems and growth factors are being developed to overcome limitations of traditional therapies.
- Novel approaches aim to enhance transplanted cell survival and therapeutic efficacy.
Conclusions:
- Combining stem cells, biomaterials, and growth factors offers a promising therapeutic avenue for myocardial infarction.
- Further research is needed to optimize these strategies for clinical application.
- Regenerative medicine holds potential for curative treatments for heart damage.
Abstract:
Myocardial infarction has been reported to be responsible for about 7.3 million deaths each year globally. Present treatments for myocardial infarction have been more palliative rather than curative. Over the past few years, stem cells have demonstrated its potency in regenerating damaged cardiac tissue, especially after myocardial infarction. However, limited short half-life of the protein and cell therapy and low transplanted cell survival rate as demonstrated via several clinical trials have lead to development of more potent and novel delivery systems like biomaterial delivery system and the use of various growth factors. In this review, we will be enumerating and discussing the recent advances in cardiac regeneration with focus on stem cell, biomaterial and growth factors.
Related Concept Videos
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Stem Cell Culture

